These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3024255)

  • 41. Nuclear magnetic resonance imaging and evaluation of human breast tissue: preliminary clinical trials.
    Ross RJ; Thompson JS; Kim K; Bailey RA
    Radiology; 1982 Apr; 143(1):195-205. PubMed ID: 7063727
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MR mammography: influence of menstrual cycle on the dynamic contrast enhancement of fibrocystic disease.
    Rieber A; Nüssle K; Merkle E; Kreienberg R; Tomczak R; Brambs HJ
    Eur Radiol; 1999; 9(6):1107-12. PubMed ID: 10415244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Proton magnetic resonance spectroscopy in the diagnosis of breast cancer].
    Meladze NV; Kuchuk PV; Abduraimov AB; Les'ko KA; Shariia MA; Malik DS; Matkhev S; Boĭko EA
    Vestn Rentgenol Radiol; 2011; (4):31-6. PubMed ID: 22288145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current status of and a critique on methods used in the diagnosis of imaged breast abnormalities: a surgeon's view.
    Martin RE
    Radiology; 1994 May; 191(2):45A-47A; discussion 47A-50A. PubMed ID: 8153320
    [No Abstract]   [Full Text] [Related]  

  • 45. [Nuclear resonance tomography of the breast--diagnosis, differential diagnosis, problems and solutions. I. Study procedures].
    Kaiser W; Zeitler E
    Rofo; 1986 Apr; 144(4):459-65. PubMed ID: 3008261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Case report: MR imaging of fat necrosis of the breast associated with lipid cyst formation following conservative treatment for breast carcinoma.
    Coady AM; Mussurakis S; Owen AW; Turnbull LW
    Clin Radiol; 1996 Nov; 51(11):815-7. PubMed ID: 8937329
    [No Abstract]   [Full Text] [Related]  

  • 47. [Nuclear magnetic resonance tomography in breast cancer diagnosis--present status and future outlook].
    Heywang SH; Hahn D; Eiermann W; Krischke I; Lissner J
    Digitale Bilddiagn; 1985 Sep; 5(3):107-11. PubMed ID: 3902323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Macromolecular contrast media for MR mammography. A new approach to characterizing breast tumors].
    Daldrup HE; Roberts TP; Mühler A; Gossmann A; Roberts HC; Wendland M; Rosenau W; Brasch RC
    Radiologe; 1997 Sep; 37(9):733-40. PubMed ID: 9424619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [MR tomography of the breast. Supplemental information in select cases].
    Friedrich M; Semmler W
    Radiologe; 1987 Apr; 27(4):165-77. PubMed ID: 3299481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Magnetic resonance imaging of the breast: functional T1 and three-dimensional imaging.
    Partain CL; Kulkarni MV; Price RR; Fleischer AC; Page DL; Malcolm AW; Winfield AC; James AE
    Cardiovasc Intervent Radiol; 1986; 8(5-6):292-9. PubMed ID: 3084093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [M. Sternalis - anomaly associated with diagnostic problems in breast cancer].
    Tsvetkova A; Gavrilova E; Gegova A; Trifonov D; Ignatov P
    Khirurgiia (Sofiia); 1998; 52(5):58-9. PubMed ID: 11247091
    [No Abstract]   [Full Text] [Related]  

  • 52. What is a useful adjunct to mammography?
    Kopans DB
    Radiology; 1986 Nov; 161(2):560-1. PubMed ID: 3532197
    [No Abstract]   [Full Text] [Related]  

  • 53. [Borderline lesion in breasts].
    Kasugai T; Mano M; Tanaka M; Ishiguro S
    Nihon Rinsho; 2000 Apr; 58 Suppl():135-9. PubMed ID: 11025986
    [No Abstract]   [Full Text] [Related]  

  • 54. Nuclear magnetic resonance: preclinical and clinical studies in tumor detection.
    Koutcher JA
    Crit Rev Oncol Hematol; 1983; 1(2):93-128. PubMed ID: 6397265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mammary tumors - MR Spectroscopy for differential diagnosis].
    Ruchalla E
    Rofo; 2013 Jun; 185(6):521. PubMed ID: 23740702
    [No Abstract]   [Full Text] [Related]  

  • 56. Identification of Key Functional Modules and Immunomodulatory Regulators of Hepatocellular Carcinoma.
    Luo D; Zhang X; Li XK; Chen G
    J Immunol Res; 2021; 2021():1801873. PubMed ID: 34423049
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Large Non-enhancing Breast Cancer on Breast Magnetic Resonance Imaging: A Case Report.
    Peters J; Tsai WC; Peters G
    Cureus; 2018 Mar; 10(3):e2332. PubMed ID: 29770285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of parallel diffusion-weighted imaging and apparent diffusion coefficient (ADC) map values for evaluating breast lesions: preliminary results.
    Jin G; An N; Jacobs MA; Li K
    Acad Radiol; 2010 Apr; 17(4):456-63. PubMed ID: 20207316
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Use of Gd-DTPA in the nuclear magnetic resonance study of the breast].
    Heywang SH; Fenzl G; Beck R; Hahn D; Eiermann W; Permanetter W; Lissner J
    Rofo; 1986 Nov; 145(5):565-71. PubMed ID: 3024255
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Dynamic contrast medium studies with flash sequences in nuclear magnetic resonance tomography of the breast].
    Heywang SH; Hilbertz T; Pruss E; Wolf A; Permanetter W; Eiermann W; Lissner J
    Digitale Bilddiagn; 1988 Mar; 8(1):7-13. PubMed ID: 3383539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.